Osteoartropatía hipertrófica primaria (paquidermoperiostosis). Aportación de 2 casos familiares y revisión de la literatura
Authors:
- 1 November 2009
- journal article
- abstracts
- Published by Elsevier in Reumatología Clínica
- Vol. 5 (6) , 259-263
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathyNature Genetics, 2008
- Hypertrophic osteoarthropathy: a palindrome with a pathogenic connotationCurrent Opinion in Rheumatology, 2008
- Interleukin (IL)‐6 and receptor activator of nuclear factor (NF)‐κB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosisScandinavian Journal of Rheumatology, 2008
- Familial pachydermoperiostosis in association with protein-losing enteropathyClinical and Experimental Dermatology, 2006
- Carnitine: a therapeutic option for childhood psoriatic onycho-pachydermo-periostitis (POPP)Clinical Rheumatology, 2006
- Pachydermoperiostosis associated with juvenile polyps of the stomach and gastric adenocarcinomaJournal of Gastroenterology, 2004
- Hypertrophic osteoarthropathy associated with pyoderma gangrenosumBritish Journal of Dermatology, 2000
- Pachydermoperiostosis: Analysis of the connective tissue abnormality in one familyJournal of the American Academy of Dermatology, 1994
- Femoral head osteonecrosis in primary hypertrophic osteoarthropathy.Annals of the Rheumatic Diseases, 1993
- The Clinical Spectrum of Pachydermoperiostosis (Primary Hypertrophic Osteoarthropathy)Medicine, 1991